For research use only
| Cat No. | ABC-SC2034 |
| Product Type | Human iPSCs |
| Cell Type | Induced Pluripotent Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Fibroblast |
| Disease | Muscular Dystrophy, Duchenne Type |
| Storage | Liquid Nitrogen |
Cell Type: iPSC; Disease: Muscular Dystrophy, Duchenne Type; DMD DYSTROPHIN; DMD.
HighQC™ Human Induced Pluripotent Stem Cells (iPSCs) From Fibroblasts – Duchenne Muscular Dystrophy (DMD) are generated from human skin fibroblasts obtained from an individual affected by Duchenne Muscular Dystrophy, a heritable neuromuscular disorder caused by mutations in the DMD gene encoding dystrophin. These cells display tight colony boundaries, high nuclear-to-cytoplasmic ratios, and clonal growth patterns. Reprogramming was performed using Sendai virus vectors, which transiently express key human transcription factors to initiate the reprogramming process. These iPSCs exhibit pluripotency, with the ability to differentiate into all three germ layers under defined conditions, and express the pluripotency marker SSEA-4. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | HighQC™ Human IPSC From Fibroblast-Muscular Dystrophy, Duchenne Type, HighQC™ hiPSC DMD, hiPSC-DMD, HighQC™ Human Induced Pluripotent Stem Cells From Fibroblast-Duchenne Muscular Dystrophy |
| Species | Human |
| Cat.No | ABC-SC2034 |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Induced Pluripotent Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Fibroblast |
| Disease | Muscular Dystrophy, Duchenne Type |
| Storage | Liquid Nitrogen |
| Product Type | Human iPSCs |
| Gene Info | Gene: DMD; Mutation: EX45DEL |
HighQC™ Human iPSCs derived from fibroblasts of individuals with Duchenne Muscular Dystrophy (DMD), also named Duchenne Muscular Dystrophy iPSCs, provide a disease-relevant in vitro platform for studying dystrophin deficiency, myogenic differentiation, and muscle development mechanisms. These cells support research on DMD gene function, cytoskeletal organization, and muscle cell maturation, as well as investigations into signaling pathways and transcriptional networks involved in neuromuscular disorders. In addition, they are well suited for directed differentiation into skeletal muscle and mesodermal lineages, enabling mechanistic studies of disease-associated cellular phenotypes under controlled experimental conditions.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Yes. These iPSCs are maintained in an undifferentiated, actively proliferating state. They have undergone rigorous quality testing, showing stable growth without significant spontaneous differentiation or loss of pluripotency, ensuring reproducible performance for downstream applications.